MANNKIND (NASDAQ:MNKD)

6.88

0.06 (0.86%)

MANNKIND (NASDAQ:MNKD) Delayed :
Previous Close	$6.94	52 Week High	$12.30
Open	$7.12	52 Week Low	$2.00
Day High	$7.24	P/E	N/A
Day Low	$6.81	EPS	$-2.35
Volume	1,394,735
More MNKD Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
ACAD	3	HOLX	3
N	3	NVO	3
WMT	3	PFE	3
HLIT	2	PEGA	2
AVCT	2	RIMM	2
SRDX	2	LF	2

View All Entities

Nov 2, 2009 04:29 PM MannKind Corp. (MNKD) Tops Views by 6c, Posts $0.42 Q3 Loss
Aug 3, 2009 04:43 PM MannKind (MNKD) Reports Q2 Loss of $0.54, Beats by 2c

Nov 2, 2009 04:29 PM MannKind Corp. (MNKD) Tops Views by 6c, Posts $0.42 Q3 Loss
Oct 14, 2009 01:52 PM Unusual 11 Mid-Day Movers 10/14: CHIO, ACPW, JADE, CNO Higher; CXM, HILL, UCBH, UPI Lower
Oct 14, 2009 11:03 AM Notable Analyst Rating Changes 10/14: CSC, GSK, SNY, ABX, CNO, HOG, TEL Upgrade; VLO, JBLU, AGCO Downgrade
Oct 14, 2009 10:46 AM Hapoalim Starts MannKind (MNKD) at Sell, $1 Price Target
Oct 8, 2009 08:14 AM MannKind (MNKD) volatility elevated after partnership delay

Nov 4, 2009 06:50AM Trading Outlook for MannKind Corp. Issued by InvestorSoup.com
Nov 2, 2009 05:00PM MannKind to Present at Upcoming Conferences
Nov 2, 2009 04:00PM MannKind Corporation Reports Third Quarter Financial Results
Oct 29, 2009 10:00AM Studies Show Early Promise of MannKind's Cancer Immunotherapy Program in Melanoma, Prostate Cancer and Other Solid Malignancies
Oct 27, 2009 06:50AM Trading Outlook for Generex Biotechnologies Corp. Issued by InvestorSoup.com

Nov 19, 2009 07:19 AM Oral-lyn vs. Afresa: How Generex Will Beat Mannkind
Nov 3, 2009 07:19 AM Wall Street Breakfast: Must-Know News
Oct 30, 2009 04:56 AM BioMed News: Rockwell Medical, EXACT Sciences, MannKind
Oct 12, 2009 05:47 PM Liking the Risk/Reward in Generex
Oct 12, 2009 03:17 AM Why I'm Taking a Foothold in Generex Now

Nov 17, 2009 04:47PM Form 4 MANNKIND CORP For: Nov 16 Filed by: Thomson David
Nov 17, 2009 04:46PM Form 4 MANNKIND CORP For: Nov 16 Filed by: Palumbo Diane
Nov 17, 2009 04:43PM Form 4 MANNKIND CORP For: Nov 16 Filed by: Edstrom Hakan
Nov 9, 2009 04:59PM Form 4 Palumbo Diane For: Nov 06
Nov 2, 2009 04:58PM Form 10-Q MANNKIND CORP For: Sep 30

Corey
on Nov 10, 2009
at 12:42 PM What'd I say! You crappy ass manipulators I told you! Hapoalim is a scam and Im makin bills up urs.
Article: Hapoalim Starts MannKind (MNKD) at Sell, $1 Price Target
Elliot
on Oct 14, 2009
at 10:59 PM Mannkind Please make sure you look back when we reach the end of January 2010 and see if you are still in business and see what the share price of MNKD is at that time
Article: Hapoalim Starts MannKind (MNKD) at Sell, $1 Price Target
corey
on Oct 14, 2009
at 03:34 PM LOL! MNKD price target of $1?? Good luck!!!! mark my post we have hit bottom at $5.68. Hapoalim Securities just lost any credibility if they even had any.
Article: Hapoalim Starts MannKind (MNKD) at Sell, $1 Price Target
corey
on Oct 14, 2009
at 03:34 PM LOL! MNKD price target of $1?? Good luck!!!! mark my post we have hit bottom at $5.68. Hapoalim Securities just lost any credibility if they even had any.
Article: Hapoalim Starts MannKind (MNKD) at Sell, $1 Price Target
Tony M
on May 18, 2008
at 11:44 AM MannKind (MNKD) Sees Upside Action Now with no other competition, and a drug that could be a revolutionary, I think the risk reward ratio is very solid.
Article: MannKind (MNKD) Sees Upside Action

View All Comments

Alfred McBride at Nov 7, 2009 05:36 PM Afresa May Stop Progression of Diabetes Type II and Prediabetes! Al Mann Mentioned that the Experts told him that Afresa might stop the progression of Diabetes! In Type II and pre-diabetes! This opens up a larger market based only on studies at this time and larger clinical trials peer reviewed will have to take place..but.. they also noted Zero Hypo's when Afresa was used Alone at a Zero Carb diet!! ZERO IN ALL CASES!!